News & Articles

Study done at the University of Cambridge suggests a way to predict prognosis and most effective treatment in cancer

We celebrate the clinical laboratory products that have made the most difference to your lab work or point-of-care testing and reveal our most popular clinical content of the year

Discover the latest technology for the identification of structural variants (SVs) within the human genome

Drop by and see SelectScience on booth #724 at this year's AACC conference in Anaheim, California, from August 4-8

Partnership strengthens IDT’s position as an NGS leader in China

Japan selects QIAGEN Clinical Insight-Interpret to handle next-generation sequencing data

Help us celebrate the best new clinical assays, kits, instruments and devices by casting your vote today

Dr. Luca Quagliata explains how molecular profiling could transform the way we treat cancer, and how his work is enabling the global adoption of this technology – in the face of clinical challenges and diversity

Don’t miss April’s highlights thanks to our regular monthly round-up of all the most popular stories and resources in the clinical science community

This new solution could enable large-scale AAV vector production for gene therapy

Catch up on all the biggest stories and top downloadable content in the clinical community in our monthly round-up

Scientists from the esteemed Institute for Genetic Medicine, Newcastle, UK, are using sophisticated consumable technologies to advance research into rare mitochondrial diseases

Extended screening service offers novel capabilities for immuno-oncology research in ex vivo T lymphocytes

We asked you how science would change the world in the next 20 years – here's what you said

DNA from 15,000 patients analyzed to identify novel genetic associations

Droplet digital PCR’s effectiveness in detecting minimal residual disease was highlighted by researchers at 60th ASH annual meeting & exposition

New results suggest the MammaTyper test could predict the likelihood of complete pathologic remission

Genomic analysis tools SIRIUS and MERCURY to be implemented into the Google Cloud Platform

We interview a scientist whose team designed AAV vectors used in a successful gene therapy clinical trial, and highlight the key technologies that supported his efforts

Contract researchers and cancer biologists, Robert B. Harris, Ph.D., Thomas Reynolds, and Gregory A. Meyers, owners and founders of NEXT Molecular Analytics, have joined the DNA sequencing revolution. To keep up their research momentum, they consider a next big step — automation

Largest African genetics resource presented at ASHG 2018 annual meeting

Findings reported at ASHG 2018 annual meeting describe new associations between environmental factors and pharmacogenes